Global Allogeneic Stem Cell Transplantation Market Growth (Status and Outlook) 2026-2032
The global Allogeneic Stem Cell Transplantation market size is predicted to grow from US$ 1152 million in 2025 to US$ 1744 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
United States market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Allogeneic Stem Cell Transplantation players cover Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Allogeneic Stem Cell Transplantation Industry Forecast” looks at past sales and reviews total world Allogeneic Stem Cell Transplantation sales in 2025, providing a comprehensive analysis by region and market sector of projected Allogeneic Stem Cell Transplantation sales for 2026 through 2032. With Allogeneic Stem Cell Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allogeneic Stem Cell Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Allogeneic Stem Cell Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Allogeneic Stem Cell Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allogeneic Stem Cell Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allogeneic Stem Cell Transplantation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allogeneic Stem Cell Transplantation.
This report presents a comprehensive overview, market shares, and growth opportunities of Allogeneic Stem Cell Transplantation market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Allogeneic Stem Cell Transplantation is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Allogeneic Stem Cell Transplantation players cover Mesoblast Limited, Gamida Cell Ltd., Novartis International AG, Cellectis SA, Magenta Therapeutics Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Allogeneic Stem Cell Transplantation Industry Forecast” looks at past sales and reviews total world Allogeneic Stem Cell Transplantation sales in 2025, providing a comprehensive analysis by region and market sector of projected Allogeneic Stem Cell Transplantation sales for 2026 through 2032. With Allogeneic Stem Cell Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Allogeneic Stem Cell Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Allogeneic Stem Cell Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Allogeneic Stem Cell Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Allogeneic Stem Cell Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Allogeneic Stem Cell Transplantation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Allogeneic Stem Cell Transplantation.
This report presents a comprehensive overview, market shares, and growth opportunities of Allogeneic Stem Cell Transplantation market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Unmodified Stem Cell Transplant
- T-cell Depleted Transplant
- Cord Blood Transplant
- Donor Lymphocyte Infusion
- Hospital
- Ambulatory Surgical Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mesoblast Limited
- Gamida Cell Ltd.
- Novartis International AG
- Cellectis SA
- Magenta Therapeutics Inc.
- Fate Therapeutics Inc.
- Cynata Therapeutics Limited
- Kiadis Pharma N.V
- Takeda Pharmaceutical Company Limited
- JCR Pharmaceuticals Co., Ltd.
- Pluristem Therapeutics Inc.
- Celularity Inc.
- Lineage Cell Therapeutics Inc.
- Nohla Therapeutics Inc.
- Orchard Therapeutics Plc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Allogeneic Stem Cell Transplantation Market Size (2021-2032)
2.1.2 Allogeneic Stem Cell Transplantation Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Allogeneic Stem Cell Transplantation by Country/Region (2021, 2025 & 2032)
2.2 Allogeneic Stem Cell Transplantation Segment by Type
2.2.1 Unmodified Stem Cell Transplant
2.2.2 T-cell Depleted Transplant
2.2.3 Cord Blood Transplant
2.2.4 Donor Lymphocyte Infusion
2.2.5 Allogeneic Stem Cell Transplantation Market Size by Type
2.2.5.1 Allogeneic Stem Cell Transplantation Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
2.3 Allogeneic Stem Cell Transplantation Segment by Application
2.3.1 Hospital
2.3.2 Ambulatory Surgical Center
2.3.3 Others
2.3.4 Allogeneic Stem Cell Transplantation Market Size by Application
2.3.4.1 Allogeneic Stem Cell Transplantation Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
3 ALLOGENEIC STEM CELL TRANSPLANTATION MARKET SIZE BY PLAYER
3.1 Allogeneic Stem Cell Transplantation Market Size Market Share by Player
3.1.1 Global Allogeneic Stem Cell Transplantation Revenue by Player (2021-2026)
3.1.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player (2021-2026)
3.2 Global Allogeneic Stem Cell Transplantation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALLOGENEIC STEM CELL TRANSPLANTATION BY REGION
4.1 Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026)
4.2 Global Allogeneic Stem Cell Transplantation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.4 APAC Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.5 Europe Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.6 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026)
5.2 Americas Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
5.3 Americas Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026)
6.2 APAC Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
6.3 APAC Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026)
7.2 Europe Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Allogeneic Stem Cell Transplantation by Region (2021-2026)
8.2 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
8.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET FORECAST
10.1 Global Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.1.1 Global Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.1.2 Americas Allogeneic Stem Cell Transplantation Forecast
10.1.3 APAC Allogeneic Stem Cell Transplantation Forecast
10.1.4 Europe Allogeneic Stem Cell Transplantation Forecast
10.1.5 Middle East & Africa Allogeneic Stem Cell Transplantation Forecast
10.2 Americas Allogeneic Stem Cell Transplantation Forecast by Country (2027-2032)
10.2.1 United States Market Allogeneic Stem Cell Transplantation Forecast
10.2.2 Canada Market Allogeneic Stem Cell Transplantation Forecast
10.2.3 Mexico Market Allogeneic Stem Cell Transplantation Forecast
10.2.4 Brazil Market Allogeneic Stem Cell Transplantation Forecast
10.3 APAC Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.3.1 China Allogeneic Stem Cell Transplantation Market Forecast
10.3.2 Japan Market Allogeneic Stem Cell Transplantation Forecast
10.3.3 Korea Market Allogeneic Stem Cell Transplantation Forecast
10.3.4 Southeast Asia Market Allogeneic Stem Cell Transplantation Forecast
10.3.5 India Market Allogeneic Stem Cell Transplantation Forecast
10.3.6 Australia Market Allogeneic Stem Cell Transplantation Forecast
10.4 Europe Allogeneic Stem Cell Transplantation Forecast by Country (2027-2032)
10.4.1 Germany Market Allogeneic Stem Cell Transplantation Forecast
10.4.2 France Market Allogeneic Stem Cell Transplantation Forecast
10.4.3 UK Market Allogeneic Stem Cell Transplantation Forecast
10.4.4 Italy Market Allogeneic Stem Cell Transplantation Forecast
10.4.5 Russia Market Allogeneic Stem Cell Transplantation Forecast
10.5 Middle East & Africa Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.5.1 Egypt Market Allogeneic Stem Cell Transplantation Forecast
10.5.2 South Africa Market Allogeneic Stem Cell Transplantation Forecast
10.5.3 Israel Market Allogeneic Stem Cell Transplantation Forecast
10.5.4 Turkey Market Allogeneic Stem Cell Transplantation Forecast
10.6 Global Allogeneic Stem Cell Transplantation Forecast by Type (2027-2032)
10.7 Global Allogeneic Stem Cell Transplantation Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Allogeneic Stem Cell Transplantation Forecast
11 KEY PLAYERS ANALYSIS
11.1 Mesoblast Limited
11.1.1 Mesoblast Limited Company Information
11.1.2 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Offered
11.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Mesoblast Limited Main Business Overview
11.1.5 Mesoblast Limited Latest Developments
11.2 Gamida Cell Ltd.
11.2.1 Gamida Cell Ltd. Company Information
11.2.2 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Offered
11.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gamida Cell Ltd. Main Business Overview
11.2.5 Gamida Cell Ltd. Latest Developments
11.3 Novartis International AG
11.3.1 Novartis International AG Company Information
11.3.2 Novartis International AG Allogeneic Stem Cell Transplantation Product Offered
11.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis International AG Main Business Overview
11.3.5 Novartis International AG Latest Developments
11.4 Cellectis SA
11.4.1 Cellectis SA Company Information
11.4.2 Cellectis SA Allogeneic Stem Cell Transplantation Product Offered
11.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cellectis SA Main Business Overview
11.4.5 Cellectis SA Latest Developments
11.5 Magenta Therapeutics Inc.
11.5.1 Magenta Therapeutics Inc. Company Information
11.5.2 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Magenta Therapeutics Inc. Main Business Overview
11.5.5 Magenta Therapeutics Inc. Latest Developments
11.6 Fate Therapeutics Inc.
11.6.1 Fate Therapeutics Inc. Company Information
11.6.2 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fate Therapeutics Inc. Main Business Overview
11.6.5 Fate Therapeutics Inc. Latest Developments
11.7 Cynata Therapeutics Limited
11.7.1 Cynata Therapeutics Limited Company Information
11.7.2 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Offered
11.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cynata Therapeutics Limited Main Business Overview
11.7.5 Cynata Therapeutics Limited Latest Developments
11.8 Kiadis Pharma N.V
11.8.1 Kiadis Pharma N.V Company Information
11.8.2 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Offered
11.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Kiadis Pharma N.V Main Business Overview
11.8.5 Kiadis Pharma N.V Latest Developments
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Information
11.9.2 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Offered
11.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.9.5 Takeda Pharmaceutical Company Limited Latest Developments
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Information
11.10.2 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Offered
11.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
11.10.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
11.11 Pluristem Therapeutics Inc.
11.11.1 Pluristem Therapeutics Inc. Company Information
11.11.2 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pluristem Therapeutics Inc. Main Business Overview
11.11.5 Pluristem Therapeutics Inc. Latest Developments
11.12 Celularity Inc.
11.12.1 Celularity Inc. Company Information
11.12.2 Celularity Inc. Allogeneic Stem Cell Transplantation Product Offered
11.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Celularity Inc. Main Business Overview
11.12.5 Celularity Inc. Latest Developments
11.13 Lineage Cell Therapeutics Inc.
11.13.1 Lineage Cell Therapeutics Inc. Company Information
11.13.2 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Lineage Cell Therapeutics Inc. Main Business Overview
11.13.5 Lineage Cell Therapeutics Inc. Latest Developments
11.14 Nohla Therapeutics Inc.
11.14.1 Nohla Therapeutics Inc. Company Information
11.14.2 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Nohla Therapeutics Inc. Main Business Overview
11.14.5 Nohla Therapeutics Inc. Latest Developments
11.15 Orchard Therapeutics Plc
11.15.1 Orchard Therapeutics Plc Company Information
11.15.2 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Offered
11.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Orchard Therapeutics Plc Main Business Overview
11.15.5 Orchard Therapeutics Plc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Allogeneic Stem Cell Transplantation Market Size (2021-2032)
2.1.2 Allogeneic Stem Cell Transplantation Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Allogeneic Stem Cell Transplantation by Country/Region (2021, 2025 & 2032)
2.2 Allogeneic Stem Cell Transplantation Segment by Type
2.2.1 Unmodified Stem Cell Transplant
2.2.2 T-cell Depleted Transplant
2.2.3 Cord Blood Transplant
2.2.4 Donor Lymphocyte Infusion
2.2.5 Allogeneic Stem Cell Transplantation Market Size by Type
2.2.5.1 Allogeneic Stem Cell Transplantation Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
2.3 Allogeneic Stem Cell Transplantation Segment by Application
2.3.1 Hospital
2.3.2 Ambulatory Surgical Center
2.3.3 Others
2.3.4 Allogeneic Stem Cell Transplantation Market Size by Application
2.3.4.1 Allogeneic Stem Cell Transplantation Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
3 ALLOGENEIC STEM CELL TRANSPLANTATION MARKET SIZE BY PLAYER
3.1 Allogeneic Stem Cell Transplantation Market Size Market Share by Player
3.1.1 Global Allogeneic Stem Cell Transplantation Revenue by Player (2021-2026)
3.1.2 Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player (2021-2026)
3.2 Global Allogeneic Stem Cell Transplantation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ALLOGENEIC STEM CELL TRANSPLANTATION BY REGION
4.1 Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026)
4.2 Global Allogeneic Stem Cell Transplantation Annual Revenue by Country/Region (2021-2026)
4.3 Americas Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.4 APAC Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.5 Europe Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
4.6 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026)
5.2 Americas Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
5.3 Americas Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026)
6.2 APAC Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
6.3 APAC Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026)
7.2 Europe Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
7.3 Europe Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Allogeneic Stem Cell Transplantation by Region (2021-2026)
8.2 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026)
8.3 Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ALLOGENEIC STEM CELL TRANSPLANTATION MARKET FORECAST
10.1 Global Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.1.1 Global Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.1.2 Americas Allogeneic Stem Cell Transplantation Forecast
10.1.3 APAC Allogeneic Stem Cell Transplantation Forecast
10.1.4 Europe Allogeneic Stem Cell Transplantation Forecast
10.1.5 Middle East & Africa Allogeneic Stem Cell Transplantation Forecast
10.2 Americas Allogeneic Stem Cell Transplantation Forecast by Country (2027-2032)
10.2.1 United States Market Allogeneic Stem Cell Transplantation Forecast
10.2.2 Canada Market Allogeneic Stem Cell Transplantation Forecast
10.2.3 Mexico Market Allogeneic Stem Cell Transplantation Forecast
10.2.4 Brazil Market Allogeneic Stem Cell Transplantation Forecast
10.3 APAC Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.3.1 China Allogeneic Stem Cell Transplantation Market Forecast
10.3.2 Japan Market Allogeneic Stem Cell Transplantation Forecast
10.3.3 Korea Market Allogeneic Stem Cell Transplantation Forecast
10.3.4 Southeast Asia Market Allogeneic Stem Cell Transplantation Forecast
10.3.5 India Market Allogeneic Stem Cell Transplantation Forecast
10.3.6 Australia Market Allogeneic Stem Cell Transplantation Forecast
10.4 Europe Allogeneic Stem Cell Transplantation Forecast by Country (2027-2032)
10.4.1 Germany Market Allogeneic Stem Cell Transplantation Forecast
10.4.2 France Market Allogeneic Stem Cell Transplantation Forecast
10.4.3 UK Market Allogeneic Stem Cell Transplantation Forecast
10.4.4 Italy Market Allogeneic Stem Cell Transplantation Forecast
10.4.5 Russia Market Allogeneic Stem Cell Transplantation Forecast
10.5 Middle East & Africa Allogeneic Stem Cell Transplantation Forecast by Region (2027-2032)
10.5.1 Egypt Market Allogeneic Stem Cell Transplantation Forecast
10.5.2 South Africa Market Allogeneic Stem Cell Transplantation Forecast
10.5.3 Israel Market Allogeneic Stem Cell Transplantation Forecast
10.5.4 Turkey Market Allogeneic Stem Cell Transplantation Forecast
10.6 Global Allogeneic Stem Cell Transplantation Forecast by Type (2027-2032)
10.7 Global Allogeneic Stem Cell Transplantation Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Allogeneic Stem Cell Transplantation Forecast
11 KEY PLAYERS ANALYSIS
11.1 Mesoblast Limited
11.1.1 Mesoblast Limited Company Information
11.1.2 Mesoblast Limited Allogeneic Stem Cell Transplantation Product Offered
11.1.3 Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Mesoblast Limited Main Business Overview
11.1.5 Mesoblast Limited Latest Developments
11.2 Gamida Cell Ltd.
11.2.1 Gamida Cell Ltd. Company Information
11.2.2 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Offered
11.2.3 Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Gamida Cell Ltd. Main Business Overview
11.2.5 Gamida Cell Ltd. Latest Developments
11.3 Novartis International AG
11.3.1 Novartis International AG Company Information
11.3.2 Novartis International AG Allogeneic Stem Cell Transplantation Product Offered
11.3.3 Novartis International AG Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis International AG Main Business Overview
11.3.5 Novartis International AG Latest Developments
11.4 Cellectis SA
11.4.1 Cellectis SA Company Information
11.4.2 Cellectis SA Allogeneic Stem Cell Transplantation Product Offered
11.4.3 Cellectis SA Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Cellectis SA Main Business Overview
11.4.5 Cellectis SA Latest Developments
11.5 Magenta Therapeutics Inc.
11.5.1 Magenta Therapeutics Inc. Company Information
11.5.2 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.5.3 Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Magenta Therapeutics Inc. Main Business Overview
11.5.5 Magenta Therapeutics Inc. Latest Developments
11.6 Fate Therapeutics Inc.
11.6.1 Fate Therapeutics Inc. Company Information
11.6.2 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.6.3 Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fate Therapeutics Inc. Main Business Overview
11.6.5 Fate Therapeutics Inc. Latest Developments
11.7 Cynata Therapeutics Limited
11.7.1 Cynata Therapeutics Limited Company Information
11.7.2 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Offered
11.7.3 Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cynata Therapeutics Limited Main Business Overview
11.7.5 Cynata Therapeutics Limited Latest Developments
11.8 Kiadis Pharma N.V
11.8.1 Kiadis Pharma N.V Company Information
11.8.2 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Offered
11.8.3 Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Kiadis Pharma N.V Main Business Overview
11.8.5 Kiadis Pharma N.V Latest Developments
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Information
11.9.2 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Offered
11.9.3 Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Takeda Pharmaceutical Company Limited Main Business Overview
11.9.5 Takeda Pharmaceutical Company Limited Latest Developments
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Information
11.10.2 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Offered
11.10.3 JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
11.10.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
11.11 Pluristem Therapeutics Inc.
11.11.1 Pluristem Therapeutics Inc. Company Information
11.11.2 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.11.3 Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Pluristem Therapeutics Inc. Main Business Overview
11.11.5 Pluristem Therapeutics Inc. Latest Developments
11.12 Celularity Inc.
11.12.1 Celularity Inc. Company Information
11.12.2 Celularity Inc. Allogeneic Stem Cell Transplantation Product Offered
11.12.3 Celularity Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Celularity Inc. Main Business Overview
11.12.5 Celularity Inc. Latest Developments
11.13 Lineage Cell Therapeutics Inc.
11.13.1 Lineage Cell Therapeutics Inc. Company Information
11.13.2 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.13.3 Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Lineage Cell Therapeutics Inc. Main Business Overview
11.13.5 Lineage Cell Therapeutics Inc. Latest Developments
11.14 Nohla Therapeutics Inc.
11.14.1 Nohla Therapeutics Inc. Company Information
11.14.2 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
11.14.3 Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Nohla Therapeutics Inc. Main Business Overview
11.14.5 Nohla Therapeutics Inc. Latest Developments
11.15 Orchard Therapeutics Plc
11.15.1 Orchard Therapeutics Plc Company Information
11.15.2 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Offered
11.15.3 Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Orchard Therapeutics Plc Main Business Overview
11.15.5 Orchard Therapeutics Plc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Allogeneic Stem Cell Transplantation Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Allogeneic Stem Cell Transplantation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Unmodified Stem Cell Transplant
Table 4. Major Players of T-cell Depleted Transplant
Table 5. Major Players of Cord Blood Transplant
Table 6. Major Players of Donor Lymphocyte Infusion
Table 7. Allogeneic Stem Cell Transplantation Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Table 10. Allogeneic Stem Cell Transplantation Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Table 13. Global Allogeneic Stem Cell Transplantation Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player (2021-2026)
Table 15. Allogeneic Stem Cell Transplantation Key Players Head office and Products Offered
Table 16. Allogeneic Stem Cell Transplantation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Table 21. Global Allogeneic Stem Cell Transplantation Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Country (2021-2026)
Table 25. Americas Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Table 27. Americas Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Table 29. APAC Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Table 31. APAC Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Country (2021-2026)
Table 35. Europe Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Allogeneic Stem Cell Transplantation
Table 41. Key Market Challenges & Risks of Allogeneic Stem Cell Transplantation
Table 42. Key Industry Trends of Allogeneic Stem Cell Transplantation
Table 43. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Mesoblast Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 48. Mesoblast Limited Allogeneic Stem Cell Transplantation Product Offered
Table 49. Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Mesoblast Limited Main Business
Table 51. Mesoblast Limited Latest Developments
Table 52. Gamida Cell Ltd. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 53. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Offered
Table 54. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Gamida Cell Ltd. Main Business
Table 56. Gamida Cell Ltd. Latest Developments
Table 57. Novartis International AG Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 58. Novartis International AG Allogeneic Stem Cell Transplantation Product Offered
Table 59. Novartis International AG Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Novartis International AG Main Business
Table 61. Novartis International AG Latest Developments
Table 62. Cellectis SA Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 63. Cellectis SA Allogeneic Stem Cell Transplantation Product Offered
Table 64. Cellectis SA Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Cellectis SA Main Business
Table 66. Cellectis SA Latest Developments
Table 67. Magenta Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 68. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 69. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Magenta Therapeutics Inc. Main Business
Table 71. Magenta Therapeutics Inc. Latest Developments
Table 72. Fate Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 73. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 74. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Fate Therapeutics Inc. Main Business
Table 76. Fate Therapeutics Inc. Latest Developments
Table 77. Cynata Therapeutics Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 78. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Offered
Table 79. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Cynata Therapeutics Limited Main Business
Table 81. Cynata Therapeutics Limited Latest Developments
Table 82. Kiadis Pharma N.V Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 83. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Offered
Table 84. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Kiadis Pharma N.V Main Business
Table 86. Kiadis Pharma N.V Latest Developments
Table 87. Takeda Pharmaceutical Company Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 88. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Offered
Table 89. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Takeda Pharmaceutical Company Limited Main Business
Table 91. Takeda Pharmaceutical Company Limited Latest Developments
Table 92. JCR Pharmaceuticals Co., Ltd. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 93. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Offered
Table 94. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. JCR Pharmaceuticals Co., Ltd. Main Business
Table 96. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 97. Pluristem Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 98. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 99. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Pluristem Therapeutics Inc. Main Business
Table 101. Pluristem Therapeutics Inc. Latest Developments
Table 102. Celularity Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 103. Celularity Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 104. Celularity Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Celularity Inc. Main Business
Table 106. Celularity Inc. Latest Developments
Table 107. Lineage Cell Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 108. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 109. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Lineage Cell Therapeutics Inc. Main Business
Table 111. Lineage Cell Therapeutics Inc. Latest Developments
Table 112. Nohla Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 113. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 114. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Nohla Therapeutics Inc. Main Business
Table 116. Nohla Therapeutics Inc. Latest Developments
Table 117. Orchard Therapeutics Plc Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 118. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Offered
Table 119. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Orchard Therapeutics Plc Main Business
Table 121. Orchard Therapeutics Plc Latest Developments
Table 1. Allogeneic Stem Cell Transplantation Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Allogeneic Stem Cell Transplantation Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Unmodified Stem Cell Transplant
Table 4. Major Players of T-cell Depleted Transplant
Table 5. Major Players of Cord Blood Transplant
Table 6. Major Players of Donor Lymphocyte Infusion
Table 7. Allogeneic Stem Cell Transplantation Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Table 10. Allogeneic Stem Cell Transplantation Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Table 13. Global Allogeneic Stem Cell Transplantation Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player (2021-2026)
Table 15. Allogeneic Stem Cell Transplantation Key Players Head office and Products Offered
Table 16. Allogeneic Stem Cell Transplantation Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Table 21. Global Allogeneic Stem Cell Transplantation Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Country (2021-2026)
Table 25. Americas Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Table 27. Americas Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Table 29. APAC Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Table 31. APAC Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Allogeneic Stem Cell Transplantation Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Country (2021-2026)
Table 35. Europe Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Allogeneic Stem Cell Transplantation
Table 41. Key Market Challenges & Risks of Allogeneic Stem Cell Transplantation
Table 42. Key Industry Trends of Allogeneic Stem Cell Transplantation
Table 43. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Allogeneic Stem Cell Transplantation Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Mesoblast Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 48. Mesoblast Limited Allogeneic Stem Cell Transplantation Product Offered
Table 49. Mesoblast Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Mesoblast Limited Main Business
Table 51. Mesoblast Limited Latest Developments
Table 52. Gamida Cell Ltd. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 53. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Product Offered
Table 54. Gamida Cell Ltd. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Gamida Cell Ltd. Main Business
Table 56. Gamida Cell Ltd. Latest Developments
Table 57. Novartis International AG Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 58. Novartis International AG Allogeneic Stem Cell Transplantation Product Offered
Table 59. Novartis International AG Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Novartis International AG Main Business
Table 61. Novartis International AG Latest Developments
Table 62. Cellectis SA Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 63. Cellectis SA Allogeneic Stem Cell Transplantation Product Offered
Table 64. Cellectis SA Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Cellectis SA Main Business
Table 66. Cellectis SA Latest Developments
Table 67. Magenta Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 68. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 69. Magenta Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Magenta Therapeutics Inc. Main Business
Table 71. Magenta Therapeutics Inc. Latest Developments
Table 72. Fate Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 73. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 74. Fate Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Fate Therapeutics Inc. Main Business
Table 76. Fate Therapeutics Inc. Latest Developments
Table 77. Cynata Therapeutics Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 78. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Product Offered
Table 79. Cynata Therapeutics Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Cynata Therapeutics Limited Main Business
Table 81. Cynata Therapeutics Limited Latest Developments
Table 82. Kiadis Pharma N.V Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 83. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Product Offered
Table 84. Kiadis Pharma N.V Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Kiadis Pharma N.V Main Business
Table 86. Kiadis Pharma N.V Latest Developments
Table 87. Takeda Pharmaceutical Company Limited Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 88. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Product Offered
Table 89. Takeda Pharmaceutical Company Limited Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Takeda Pharmaceutical Company Limited Main Business
Table 91. Takeda Pharmaceutical Company Limited Latest Developments
Table 92. JCR Pharmaceuticals Co., Ltd. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 93. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Product Offered
Table 94. JCR Pharmaceuticals Co., Ltd. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. JCR Pharmaceuticals Co., Ltd. Main Business
Table 96. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 97. Pluristem Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 98. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 99. Pluristem Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Pluristem Therapeutics Inc. Main Business
Table 101. Pluristem Therapeutics Inc. Latest Developments
Table 102. Celularity Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 103. Celularity Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 104. Celularity Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Celularity Inc. Main Business
Table 106. Celularity Inc. Latest Developments
Table 107. Lineage Cell Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 108. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 109. Lineage Cell Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Lineage Cell Therapeutics Inc. Main Business
Table 111. Lineage Cell Therapeutics Inc. Latest Developments
Table 112. Nohla Therapeutics Inc. Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 113. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Product Offered
Table 114. Nohla Therapeutics Inc. Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 115. Nohla Therapeutics Inc. Main Business
Table 116. Nohla Therapeutics Inc. Latest Developments
Table 117. Orchard Therapeutics Plc Details, Company Type, Allogeneic Stem Cell Transplantation Area Served and Its Competitors
Table 118. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Product Offered
Table 119. Orchard Therapeutics Plc Allogeneic Stem Cell Transplantation Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 120. Orchard Therapeutics Plc Main Business
Table 121. Orchard Therapeutics Plc Latest Developments
LIST OF FIGURES
Figure 1. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Allogeneic Stem Cell Transplantation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Allogeneic Stem Cell Transplantation Sales Market Share by Country/Region (2025)
Figure 8. Allogeneic Stem Cell Transplantation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type in 2025
Figure 10. Allogeneic Stem Cell Transplantation in Hospital
Figure 11. Global Allogeneic Stem Cell Transplantation Market: Hospital (2021-2026) & ($ millions)
Figure 12. Allogeneic Stem Cell Transplantation in Ambulatory Surgical Center
Figure 13. Global Allogeneic Stem Cell Transplantation Market: Ambulatory Surgical Center (2021-2026) & ($ millions)
Figure 14. Allogeneic Stem Cell Transplantation in Others
Figure 15. Global Allogeneic Stem Cell Transplantation Market: Others (2021-2026) & ($ millions)
Figure 16. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application in 2025
Figure 17. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player in 2025
Figure 18. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Figure 19. Americas Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 20. APAC Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 21. Europe Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 23. Americas Allogeneic Stem Cell Transplantation Value Market Share by Country in 2025
Figure 24. United States Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Region in 2025
Figure 29. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 30. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 31. China Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 35. India Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Country in 2025
Figure 38. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 39. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 40. Germany Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 41. France Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 54. APAC Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 55. Europe Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 57. United States Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 58. Canada Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 59. Mexico Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 60. Brazil Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 61. China Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 62. Japan Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 63. Korea Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 65. India Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 66. Australia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 67. Germany Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 68. France Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 69. UK Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 70. Italy Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 71. Russia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 72. Egypt Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 73. South Africa Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 74. Israel Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 75. Turkey Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 76. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 1. Allogeneic Stem Cell Transplantation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Allogeneic Stem Cell Transplantation Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Allogeneic Stem Cell Transplantation Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Allogeneic Stem Cell Transplantation Sales Market Share by Country/Region (2025)
Figure 8. Allogeneic Stem Cell Transplantation Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Type in 2025
Figure 10. Allogeneic Stem Cell Transplantation in Hospital
Figure 11. Global Allogeneic Stem Cell Transplantation Market: Hospital (2021-2026) & ($ millions)
Figure 12. Allogeneic Stem Cell Transplantation in Ambulatory Surgical Center
Figure 13. Global Allogeneic Stem Cell Transplantation Market: Ambulatory Surgical Center (2021-2026) & ($ millions)
Figure 14. Allogeneic Stem Cell Transplantation in Others
Figure 15. Global Allogeneic Stem Cell Transplantation Market: Others (2021-2026) & ($ millions)
Figure 16. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Application in 2025
Figure 17. Global Allogeneic Stem Cell Transplantation Revenue Market Share by Player in 2025
Figure 18. Global Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Figure 19. Americas Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 20. APAC Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 21. Europe Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size 2021-2026 ($ millions)
Figure 23. Americas Allogeneic Stem Cell Transplantation Value Market Share by Country in 2025
Figure 24. United States Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Region in 2025
Figure 29. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 30. APAC Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 31. China Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 35. India Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Country in 2025
Figure 38. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 39. Europe Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 40. Germany Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 41. France Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Allogeneic Stem Cell Transplantation Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 54. APAC Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 55. Europe Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 57. United States Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 58. Canada Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 59. Mexico Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 60. Brazil Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 61. China Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 62. Japan Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 63. Korea Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 65. India Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 66. Australia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 67. Germany Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 68. France Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 69. UK Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 70. Italy Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 71. Russia Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 72. Egypt Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 73. South Africa Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 74. Israel Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 75. Turkey Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
Figure 76. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Allogeneic Stem Cell Transplantation Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Allogeneic Stem Cell Transplantation Market Size 2027-2032 ($ millions)
